In March 2024, the FDA approved the first over-the-counter continuous glucose monitors (CGMs), marking a quiet but significant shift in how we can track and understand our health. Devices like ...
Back at CES 2024, we wrote about the Dexcom Stelo – a new continuous glucose monitor (CGM) aimed at pre-diabetics and Type 2 sufferers. Stelo has now been cleared by the FDA and will be the first over ...
SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today that the FDA has cleared Stelo by Dexcom ...
Dexcom on Monday announced its new over-the-counter continuous glucose monitor Stelo is officially available for purchase in the U.S. Glucose is a type of sugar people receive from food, and it's the ...
Wearable glucose trackers have moved from the pharmacy counter to the checkout aisle, and the OTC CGM comparison shoppers are now making at home looks a lot like the one diabetes patients used to ...
Dexcom’s Stelo is the first over-the-counter continuous glucose monitor cleared for children. The FDA decision expands app-based glucose tracking to younger users, but schools, health care teams, and ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results